The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126813623 12681362 3 F 20160310 20160513 20160824 20160902 EXP FR-PFIZER INC-2016390035 PFIZER 69.00 YR M Y 0.00000 20160902 OT FR FR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126813623 12681362 1 PS Amlor AMLODIPINE BESYLATE 1 Oral 1 DF, DAILY 65 MG Y 19787 1 DF CAPSULE, HARD
126813623 12681362 2 SS TAHOR ATORVASTATIN CALCIUM 1 Oral UNK Y 20702
126813623 12681362 3 SS CORDARONE AMIODARONE HYDROCHLORIDE 1 Oral UNK Y 18972 TABLET
126813623 12681362 4 SS ZYDELIG IDELALISIB 1 Oral 2 DF, DAILY 8700 MG Y 0 2 DF FILM-COATED TABLET
126813623 12681362 5 SS BACTRIM SULFAMETHOXAZOLETRIMETHOPRIM 1 Oral UNK Y 0 TABLET
126813623 12681362 6 SS ZELITREX VALACYCLOVIR HYDROCHLORIDE 1 Oral 1 DF, UNK 0 1 DF COATED TABLET
126813623 12681362 7 SS CALCIPARINE HEPARIN CALCIUM 1 UNK Y 0
126813623 12681362 8 SS LOXEN L P NICARDIPINE HYDROCHLORIDE 1 Oral 2 DF, 2X/DAY Y 0 2 DF PROLONGED-RELEASE CAPSULE BID
126813623 12681362 9 SS LASILIX RETARD FUROSEMIDE 1 Oral 60 MG, UNK Y 0 60 MG CAPSULE
126813623 12681362 10 SS LASILIX /00032601/ FUROSEMIDE 1 Oral UNK Y 0
126813623 12681362 11 C DEXAMETHASONE. DEXAMETHASONE 1 UNK 0
126813623 12681362 12 C EUPANTOL PANTOPRAZOLE SODIUM 1 UNK 0
126813623 12681362 13 C DUPHALAC LACTULOSE 1 UNK 0
126813623 12681362 14 C ATROVENT IPRATROPIUM BROMIDE 1 UNK 0
126813623 12681362 15 C VENTOLINE /00139501/ ALBUTEROL 1 UNK 0
126813623 12681362 16 C TRIATEC /00885601/ RAMIPRIL 1 1.25 MG, UNK 0 1.25 MG
126813623 12681362 17 C PENTACARINAT PENTAMIDINE ISETHIONATE 1 UNK 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126813623 12681362 1 Hypertension
126813623 12681362 4 Waldenstrom's macroglobulinaemia
126813623 12681362 7 Face oedema
126813623 12681362 8 Hypertension

Outcome of event

Event ID CASEID OUTC COD
126813623 12681362 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
126813623 12681362 Dermatitis exfoliative

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126813623 12681362 1 20160227 20160411 0
126813623 12681362 2 20160201 20160422 0
126813623 12681362 3 20160524 0
126813623 12681362 4 20160211 20160603 0
126813623 12681362 5 20160211 20160218 0
126813623 12681362 6 20160211 0
126813623 12681362 7 20160227 20160411 0
126813623 12681362 8 20160422 20160603 0
126813623 12681362 9 20160411 0
126813623 12681362 10 20160211 20160531 0
126813623 12681362 17 201603 0